Interleukin-17 is a potential player and treatment target in severe chronic spontaneous urticaria.

D A SabagL MatanesJ BejarH ShefferA BarzilaiM K ChurchE ToubiMarcus Maurer Zahava Vadasz

Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2021)

These findings suggest that IL-17 is involved in the pathogenesis of CSU and that IL-17 should be investigated as a therapeutic target in future studies with larger numbers of patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
risk assessment
current status
climate change
high resolution